Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solis Pharmaceuticals is an Indian pharmaceutical company focused on the development, manufacturing, and export of a broad range of generic pharmaceutical formulations. The company's product portfolio includes tablets, capsules, liquid orals, and injectables across major therapeutic segments such as anti-infectives, cardiovascular health, gastroenterology, and analgesics. Solis Pharmaceuticals operates with a focus on providing high-quality, affordable healthcare solutions to global markets, maintaining a significant presence in emerging economies across Africa, South East Asia, and Latin America. In addition to its own product line, the company provides contract manufacturing services (CMO) to international partners, adhering to Good Manufacturing Practices (GMP) and international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solis Pharma.